Literature DB >> 1649654

Hepatitis A.

A J Tilzey, J E Banatvala.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1649654      PMCID： PMC1670318          DOI： 10.1136/bmj.302.6792.1552

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  10 in total

1.  Safety and immunogenicity of an inactivated hepatitis A candidate vaccine in healthy adult volunteers.

Authors:  G Wiedermann; F Ambrosch; H Kollaritsch; H Hofmann; C Kunz; E D'Hondt; A Delem; F E André; A Safary; J Stéphenne
Journal:  Vaccine       Date:  1990-12       Impact factor: 3.641

Review 2.  Prospects for a hepatitis A virus vaccine.

Authors:  B Flehmig; U Heinricy; M Pfisterer
Journal:  Prog Med Virol       Date:  1990

Review 3.  Inactivated candidate vaccines for hepatitis A.

Authors:  F E André; A Hepburn; E D'Hondt
Journal:  Prog Med Virol       Date:  1990

4.  Immunogenicity of a killed hepatitis A vaccine in seronegative volunteers.

Authors:  B Flehmig; U Heinricy; M Pfisterer
Journal:  Lancet       Date:  1989-05-13       Impact factor: 79.321

5.  Relapsing hepatitis associated with hepatitis A virus.

Authors:  L D Gruer; M W McKendrick; N J Beeching; A M Geddes
Journal:  Lancet       Date:  1982-07-17       Impact factor: 79.321

6.  Hepatitis A antibodies in London blood donors, medical students, and patients.

Authors:  J E Banatvala; R J Thorogood
Journal:  Lancet       Date:  1980-03-15       Impact factor: 79.321

7.  Primary study of attenuated live hepatitis A vaccine (H2 strain) in humans.

Authors:  J S Mao; D X Dong; H Y Zhang; N L Chen; X Y Zhang; H Y Huang; R Y Xie; T J Zhou; Z J Wan; Y Z Wang
Journal:  J Infect Dis       Date:  1989-04       Impact factor: 5.226

Review 8.  Design of hepatitis A vaccines.

Authors:  I D Gust
Journal:  Br Med Bull       Date:  1990-04       Impact factor: 4.291

9.  Relapsing viral hepatitis type A.

Authors:  I M Jacobson; B J Nath; J L Dienstag
Journal:  J Med Virol       Date:  1985-06       Impact factor: 2.327

10.  Development of live, attenuated hepatitis A vaccine (H2-strain).

Authors:  J S Mao
Journal:  Vaccine       Date:  1990-12       Impact factor: 3.641
  10 in total
  15 in total

1.  An outbreak of hepatitis A in Gloucester, UK.

Authors:  F A Majeed; J M Stuart; K A Cartwright; R Room; J R Gilkes; M C Smith; B E Watson
Journal:  Epidemiol Infect       Date:  1992-08       Impact factor: 2.451

2.  Cost effectiveness of alternative hepatitis A immunisation strategies.

Authors:  E van Doorslaer; G Tormans; P van Damme; P Beutels
Journal:  Pharmacoeconomics       Date:  1995-07       Impact factor: 4.981

Review 3.  Sexually transmitted hepatitis: a review.

Authors:  R J Gilson
Journal:  Genitourin Med       Date:  1992-04

4.  Hepatitis A vaccine.

Authors:  C M Regan; Q Syed; A Corkery
Journal:  BMJ       Date:  1991-08-17

5.  Hepatitis A immunisation.

Authors: 
Journal:  BMJ       Date:  1991-07-27

6.  Notification of hepatitis A.

Authors:  R White; J Cheesbrough; D Zala
Journal:  BMJ       Date:  1991-09-28

7.  Hepatitis A infection: a seroepidemiological study in young adults in North-East Italy.

Authors:  M E Moschen; A Floreani; E Zamparo; V Baldo; S Majori; V Gasparini; R Trivello
Journal:  Eur J Epidemiol       Date:  1997-12       Impact factor: 8.082

8.  Prevalence of hepatitis A antibody among disadvantaged gypsy children in northern Spain.

Authors:  G Cilla; E Perez-Trallero; J M Marimon; S Erdozain; C Gutierrez
Journal:  Epidemiol Infect       Date:  1995-08       Impact factor: 2.451

9.  Salivary antibody testing in a school outbreak of hepatitis A.

Authors:  J M Stuart; F A Majeed; K A Cartwright; R Room; J V Parry; K R Perry; N T Begg
Journal:  Epidemiol Infect       Date:  1992-08       Impact factor: 2.451

10.  Is travel prophylaxis worth while? Economic appraisal of prophylactic measures against malaria, hepatitis A, and typhoid in travellers.

Authors:  R H Behrens; J A Roberts
Journal:  BMJ       Date:  1994-10-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.